Thrombolytic therapy in myocardial infarction.
D002986:Clinical Trials as Topic; D010450:Endopeptidases / Q000627:therapeutic use*; D005260:Female; D005341:Fibrinolysin / Q000627:therapeutic use; D005500:Follow-Up Studies; D006321:Heart / Q000503:physiopathology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D006493:Heparin; D010450:Endopeptidases; D013300:Streptokinase; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator